Skip to Main Content

Author Details

Amy Lum
University of British Columbia
2014
40
21
PMIDPaper TitleJournal TitlePublished Year
36853783p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk.Mod Pathol2023
37580913Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.Histopathology2023
37321155Harmonized molecular classification; assessment of a single-test ProMisE NGS tool.Gynecol Oncol2023
37022464Outcomes of a radiation sparing approach in medulloblastoma by subgroup in young children: an institutional review.Childs Nerv Syst2023
37182372Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085].Mod Pathol2023
36977195KRAS mutations and endometriosis burden of disease.J Pathol Clin Res2023
36753816Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.Gynecol Oncol2023
36788084Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.Mod Pathol2023
35246332Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification.Gynecol Oncol2022
35504673Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.Gynecol Oncol2022
35526077Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma.Acta Neuropathol Commun2022
33125840SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.J Pathol Clin Res2021
34926770Protracted clinical course of an AFF1 fusion positive uterine smooth muscle tumor causing diagnostic confusion over a course of 15 years.Gynecol Oncol Rep2021
31609487Characterisation of isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 gene mutation and the d-2-hydroxyglutarate oncometabolite level in dedifferentiated chondrosarcoma.Histopathology2020
33115448TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.BMC Biol2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
30428062Iatrogenic endometriosis harbors somatic cancer-driver mutations.Hum Reprod2019
30093628Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer.Oncogene2019
31553692Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum.J Clin Oncol2019
31187483Oncogenic mutations in histologically normal endometrium: the new normal?J Pathol2019
30922603Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma.Gynecol Oncol2019
31094921Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.Am J Surg Pathol2019
29148539Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.Mod Pathol2018
30144186Novel EPC1 gene fusions in endometrial stromal sarcoma.Genes Chromosomes Cancer2018
29660837DICER1 hot-spot mutations in ovarian gynandroblastoma.Histopathology2018
29432521Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.Ann Oncol2018
28061006Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.Cancer2017
28489996Cancer-Associated Mutations in Endometriosis without Cancer.N Engl J Med2017
29032825LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers.Gynecol Oncol2017
28594898Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.PLoS One2017
27810330FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor.J Mol Diagn2017
27259007ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors.Am J Surg Pathol2016
27421752Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.Gynecol Oncol2016
25798586Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.PLoS One2015
26331834Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.J Mol Diagn2015
26182300Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.JAMA Oncol2015
25656989Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.BMC Cancer2015
24903541Somatic mosaicism for the p.His1047Arg mutation in PIK3CA in a girl with mesenteric lipomatosis.Am J Med Genet A2014
24807916Diagnostic value of next-generation sequencing in an unusual sphenoid tumor.Oncologist2014
  • 1 - 40 of 40

Recommended Authors

David N Brown
Memorial Sloan Kettering Cancer Center
Career Start Year 2018
Number of shared co-authors 1
Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 5
Reanne Bowlby
Career Start Year 2015
Number of shared co-authors 10
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 2
Cathleen Matrai
Weill Cornell Medical Center
Career Start Year 2013
Number of shared co-authors 0
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Career Start Year 2012
Number of shared co-authors 0
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 1
Ghassan Allo
Henry Ford Hospital
Career Start Year 2011
Number of shared co-authors 11
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 9
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 13
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 9
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 3
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 35
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 3
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 6
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 18
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 0
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 3
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 8
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 2
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 26
Blaise A Clarke
University of Toronto.
Career Start Year 2001
Number of shared co-authors 55
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 2
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 41
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 6
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 6
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 6
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 43
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 5
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 4

Collaborators

David G Huntsman
University of British Columbia
Co-authored papers 24
Cyril B Gilks
University of British Columbia
Co-authored papers 19
Janine Senz
University of British Columbia
Co-authored papers 15
Aline Talhouk
The University of British Columbia
Co-authored papers 13
Samuel Leung
University of British Columbia
Co-authored papers 12
Michael S Anglesio
University of British Columbia
Co-authored papers 10
Martin K??bel
University of Calgary
Co-authored papers 10
Tayyebeh M Nazeran
University of British Columbia
Co-authored papers 8
Stefan Kommoss
Eberhard Karls University Tubingen
Co-authored papers 8
Derek S Chiu
University of British Columbia, and Vancouver General Hospital
Co-authored papers 7
Marco A Marra
University of British Columbia
Co-authored papers 5
Steven J M Jones
University of British Columbia
Co-authored papers 4
Shahrad Rod Rassekh
British Columbia Children's Hospital, The University of British Columbia
Co-authored papers 3
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 3
Janessa Laskin
Co-authored papers 3
Naveena Singh
Barts Health NHS Trust
Co-authored papers 3
Joy Hendley
Peter MacCallum Cancer Centre
Co-authored papers 2
Mary Anne Rossing
Fred Hutchinson Cancer Research Center
Co-authored papers 2
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 2
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 2
Helen Steed
University of Alberta, Canada Cross Cancer Institute
Co-authored papers 2
Nadia Traficante
Peter MacCallum Cancer Centre
Co-authored papers 2
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 2
Rosalind Glasspool
University of Glasgow
Co-authored papers 2
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 2
Michelle J Henderson
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 2
Chloe Karpinskyj
Institute of Clinical Trials and Methodology, University College London
Co-authored papers 2
Michael E Carney
John A. Burns School of Medicine, University of Hawaii
Co-authored papers 2
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 2
Valerie Rhenius
University of Cambridge
Co-authored papers 2
Release 1.2